Viemed Healthcare, Inc.
Symbol: VMD
NASDAQ
9.38
USDTržní cena dnes
26.7260
Poměr P/E
0.0462
Poměr PEG
361.03M
MRK Cap
- 0.00%
Výnos DIV
Viemed Healthcare, Inc. (VMD) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 12.8 | 16.9 | 28.4 | ||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -2 | 0 | ||||||||
balance-sheet.row.net-receivables | 0 | 18.4 | 15.4 | 14.7 | ||||||||
balance-sheet.row.inventory | 0 | 4.6 | 3.6 | 2.5 | ||||||||
balance-sheet.row.other-current-assets | 0 | 2.4 | 3.8 | 1.7 | ||||||||
balance-sheet.row.total-current-assets | 0 | 38.2 | 39.7 | 47.3 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 76.5 | 68.4 | 62.8 | ||||||||
balance-sheet.row.goodwill | 0 | 29.6 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0.6 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 30.3 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 3.9 | 4.2 | 2.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 4.5 | 3.1 | 4.8 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.7 | 1.6 | 0.9 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 115.9 | 77.3 | 70.7 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.account-payables | 0 | 4.2 | 2.6 | 3.2 | ||||||||
balance-sheet.row.short-term-debt | 0 | 2 | 0.5 | 1.9 | ||||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6 | 0.2 | 4.6 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 19.6 | 11.1 | 8.9 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8.8 | 1.1 | 5.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.3 | 0.7 | 0.7 | ||||||||
balance-sheet.row.total-liab | 0 | 40.8 | 19.9 | 23.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 18.6 | 15.1 | 14 | ||||||||
balance-sheet.row.retained-earnings | 0 | 79.1 | 69.8 | 73.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.3 | -0.3 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 15.6 | 12.1 | 7.7 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 3.9 | 2.2 | 2.2 | ||||||||
balance-sheet.row.total-debt | 0 | 10.3 | 0.7 | 6.5 | ||||||||
balance-sheet.row.net-debt | 0 | -2.5 | -16.2 | -21.9 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 10.4 | 6.2 | 9.1 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 22.3 | 15.6 | 11.3 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -1.5 | 1.7 | 3.9 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 5.8 | 5.2 | 5.2 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 7.9 | -10.1 | -13.6 | ||||||||
cash-flows.row.account-receivables | 0 | -1.1 | -12.6 | -7.3 | ||||||||
cash-flows.row.inventory | 0 | -0.5 | 0.3 | -0.2 | ||||||||
cash-flows.row.account-payables | 0 | -0.9 | -0.3 | 0.1 | ||||||||
cash-flows.row.other-working-capital | 0 | 10.4 | 2.4 | -6.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 1 | 9.1 | 6.6 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.acquisitions-net | 0 | -26.5 | -0.1 | -0.6 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -0.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -2.6 | 0 | 0.6 | ||||||||
cash-flows.row.other-investing-activites | 0 | 2.6 | 1.1 | 0.6 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -53.1 | -24 | -19.7 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.3 | -5.8 | -4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 0.3 | 0.1 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.6 | -9.7 | -1.4 | ||||||||
cash-flows.row.dividends-paid | 0 | -0.4 | -0.3 | -0.1 | ||||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.3 | 0.1 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.9 | -15.3 | -5.3 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 6.9 | -11.5 | -2.6 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 12.8 | 16.9 | 28.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 5.9 | 28.4 | 31 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 46 | 27.7 | 22.5 | ||||||||
cash-flows.row.capital-expenditure | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.free-cash-flow | 0 | 19.5 | 4.8 | 2.8 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 186.4 | 138.8 | 117.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 72.9 | 54.2 | 43.7 | ||||||||
income-statement-row.row.gross-profit | 0 | 113.4 | 84.7 | 73.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.operating-expenses | 0 | 97.6 | 76.1 | 61.4 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 170.6 | 130.2 | 105 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 0.3 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 22.3 | 16.3 | 12.2 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 15.8 | 8.3 | 11.6 | ||||||||
income-statement-row.row.income-before-tax | 0 | 14.7 | 9 | 12.5 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 4.2 | 2.8 | 3.4 | ||||||||
income-statement-row.row.net-income | 0 | 10.2 | 6.2 | 9.1 |
Často kladené otázky
Co je Viemed Healthcare, Inc. (VMD) celková aktiva?
Viemed Healthcare, Inc. (VMD) celková aktiva jsou 154102510.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.609.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 0.228.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.053.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.077.
Co je Viemed Healthcare, Inc. (VMD) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 10243000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 10271179.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 97637306.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.